| Financial Year |
March 31 2023 |
| Monetary Funds |
808,951,270.81 |
| Held-for-trading Financial Assets |
500,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
38,193,525.26 |
| Advances to Suppliers |
483,270.00 |
| Other Receivables |
201,611,257.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,551,033.31 |
| Total Current Assets |
1,052,290,356.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
46,835,952.63 |
| Investment Properties |
447,068.40 |
| Fixed Assetes |
1,943,154,880.10 |
| Under-construction Projects |
325,065,597.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,152,714,585.84 |
| R&D expenses |
-- |
| Goodwill |
99,867,720.38 |
| Long-Term Deferred and Prepaid Expenses |
262,847,622.31 |
| Deferred Income Tax Assets |
597,669,088.39 |
| Other Non-Current Assets |
1,654,201,029.49 |
| Sub-Total of Non-Current Assets |
7,365,349,597.25 |
| Total Assets |
8,417,639,954.21 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
280,605,911.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
322,270,742.31 |
| Taxes Payable |
22,675,539.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,095,716,952.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
548,561,255.14 |
| Other Current Liabilities |
107,737,249.07 |
| Sub-Total of Current Liabilities |
6,968,809,286.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
87,727,532.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
644,635,590.92 |
| Total Liabilities |
7,613,444,877.00 |
| Paid-In Capital(Or Share Stock) |
103,807,623.00 |
| Capital Surplus |
1,225,481,049.50 |
| Surplus Reserve |
45,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-576,426,960.06 |
| Minority Stockholder's Interest |
-41,635.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
804,236,712.44 |
| Owner's Equity（Stockholder's Equity） |
804,195,077.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,417,639,954.21 |
